Please login to the form below

Not currently logged in
Email:
Password:

Marschall Runge joins Lilly’s board of directors

Will serve on the pharma company's Science and Technology, and Public Policy and Compliance Committees

Lilly Marschall Runge Lilly has added academic experience to its board of directors with the appointment of Dr Marschall Runge, who is executive dean for the School of Medicine at the University of North Carolina (UNC).

Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare to provide advice on company strategies.

This experience includes his current role at UNC, where he provides overall academic and clinical leadership for the School of Medicine.

Dr Runge also currently serves as principal investigator and director of the North Carolina Translational and Clinical Sciences (NC TraCS), one of 60 medical research institutions that form a national consortium to improve the way biomedical research is conducted across the US.

His previous positions include faculty member at Harvard's Massachusetts General Hospital and associate professor of medicine at Emory University.

“Dr Runge brings to the Lilly board a broad background in healthcare, with extensive experience as a practicing physician, clinical researcher, and dean of a major academic medical institution,” said Dr John Lechleiter, Lilly's chairman, president and CEO.

“His appreciation of the importance of scientific research, coupled with his first-hand experience in patient care, will help Lilly deliver on its commitment to discover and develop innovative medicines that make a difference for patients in need."

30th August 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...

Infographics